All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0676 | Anti-HOXB13 (CBFYH-1763) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1763 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0755 | Anti-HOXB13 (CBFYH-1759) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1759 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1315 | Anti-HOXB13 (CBFYH-1760) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1760 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1316 | Anti-HOXB13 (CBFYH-1761) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1761 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1317 | Anti-HOXB13 (CBFYH-1762) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1762 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3929 | Anti-HOXB13 (CBFYH-1763) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1763 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4008 | Anti-HOXB13 (CBFYH-1759) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1759 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4568 | Anti-HOXB13 (CBFYH-1760) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1760 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4569 | Anti-HOXB13 (CBFYH-1761) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1761 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4570 | Anti-HOXB13 (CBFYH-1762) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-1762 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION